Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
about
Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.Effects of structural modifications on the metal binding, anti-amyloid activity, and cholinesterase inhibitory activity of chalcones.Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.A novel hybrid of 6-chlorotacrine and metal–amyloid-β modulator for inhibition of acetylcholinesterase and metal-induced amyloid-β aggregation
P2860
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2011
@uk
name
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@en
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@nl
type
label
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@en
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@nl
prefLabel
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@en
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@nl
P2093
P2860
P356
P1433
P1476
Tacrine-mefenamic acid hybrids for inhibition of acetylcholinesterase
@en
P2093
Christopher K. Jones
Jacob L. Houghton
Joshua J. Bornstein
Keith D. Green
Todd J. Eckroat
P2860
P356
10.1039/C0MD00256A
P577
2011-01-01T00:00:00Z